Most bought healthcare stocks in Q4 2015
See which Healthcare stocks institutional investors increased the most in Q4 2015, measured as net growth in reported share positions from Q3 2015 into Q4 2015. Notable additions at the top of this list include TEVA PHARMACEUTICAL-SP ADR (TEVA), ASTRAZENECA PLC-SPONS ADR (AZN), AGILENT TECHNOLOGIES INC (A), ELEVANCE HEALTH INC (ELV). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 13,608,120 | $1.05M | 0 | 1 | 3 | 0 | 5 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 11,290,182 | $394.98K | 2 | 0 | 1 | 0 | 4 |
| A | AGILENT TECHNOLOGIES INC | 4,545,754 | $222.41K | 2 | 0 | 1 | 1 | 4 |
| ELV | ELEVANCE HEALTH INC | 4,161,723 | $574.19K | 0 | 4 | 3 | 0 | 7 |
| UNH | UNITEDHEALTH GROUP INC | 1,983,302 | $269.13K | 0 | 7 | 1 | 0 | 8 |
| EW | EDWARDS LIFESCIENCES CORP | 1,917,715 | $50.51K | 0 | 2 | 0 | 0 | 2 |
| BSX | BOSTON SCIENTIFIC CORP | 1,837,640 | $38.12K | 1 | 0 | 1 | 1 | 2 |
| IDXX | IDEXX LABORATORIES INC | 1,705,282 | $123.13K | 0 | 2 | 0 | 0 | 3 |
| HOLX | HOLOGIC INC | 1,655,357 | -$220.39K | 1 | 1 | 0 | 1 | 3 |
| ZTS | ZOETIS INC | 1,655,300 | $367.18K | 1 | 0 | 1 | 0 | 3 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 1,575,275 | $20.79K | 1 | 0 | 0 | 1 | 1 |
| JNJ | JOHNSON & JOHNSON | 1,449,726 | $17.15M | 0 | 8 | 7 | 0 | 19 |
| HUM | HUMANA INC | 858,851 | $150.84K | 2 | 2 | 0 | 0 | 4 |
| SYK | STRYKER CORP | 801,687 | $67.31K | 1 | 3 | 1 | 1 | 5 |
| GILD | GILEAD SCIENCES INC | 756,548 | -$2.08M | 0 | 4 | 7 | 0 | 13 |
| COR | CENCORA INC | 628,900 | $72.03K | 0 | 1 | 0 | 0 | 1 |
| DXCM | DEXCOM INC | 557,300 | $45.10K | 0 | 1 | 0 | 0 | 1 |
| EXEL | EXELIXIS INC | 551,350 | $3.11K | 1 | 0 | 0 | 0 | 1 |
| PDCO | PATTERSON COS INC | 547,469 | $48.47K | 0 | 1 | 3 | 1 | 4 |
| BIIB | BIOGEN INC | 528,538 | $162.44K | 3 | 0 | 0 | 1 | 4 |
| WAT | WATERS CORP | 501,445 | $112.50K | 0 | 4 | 0 | 0 | 4 |
| OSUR | ORASURE TECHNOLOGIES INC | 426,407 | $5.84K | 0 | 1 | 0 | 0 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | 408,736 | $188.98K | 0 | 3 | 3 | 0 | 7 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 381,421 | $58.03K | 0 | 4 | 1 | 1 | 6 |
| ESPR | ESPERION THERAPEUTICS INC | 361,200 | $8.04K | 1 | 0 | 0 | 0 | 1 |
| ALGN | ALIGN TECHNOLOGY INC | 342,806 | $35.62K | 0 | 1 | 1 | 0 | 2 |
| VNDA | VANDA PHARMACEUTICALS INC | 337,390 | $3.14K | 1 | 0 | 0 | 0 | 1 |
| MRK | MERCK & CO. INC. | 320,136 | $8.84M | 1 | 5 | 3 | 2 | 10 |
| NVS | NOVARTIS AG-SPONSORED ADR | 308,558 | -$505.40K | 1 | 2 | 3 | 1 | 8 |
| CYTK | CYTOKINETICS INC | 299,578 | $3.96K | 0 | 1 | 0 | 0 | 1 |
| ARAY | ACCURAY INC | 278,800 | $5.39K | 0 | 1 | 0 | 0 | 1 |
| AZTA | AZENTA INC | 271,657 | $2.58K | 0 | 2 | 0 | 0 | 2 |
| AMRN | AMARIN CORP PLC -ADR | 264,900 | $501 | 1 | 0 | 0 | 0 | 1 |
| ABUS | ARBUTUS BIOPHARMA CORP | 245,900 | $913 | 0 | 1 | 0 | 0 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 239,700 | $13.33K | 0 | 1 | 0 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | 235,800 | $19.96K | 0 | 1 | 0 | 1 | 1 |
| ACHC | ACADIA HEALTHCARE CO INC | 223,100 | $13.94K | 1 | 0 | 0 | 0 | 1 |
| AMN | AMN HEALTHCARE SERVICES INC | 221,771 | $7.09K | 0 | 1 | 0 | 0 | 1 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 211,300 | $2.48K | 0 | 1 | 0 | 0 | 1 |
| OMI | OWENS & MINOR INC | 201,977 | $11.57K | 0 | 1 | 1 | 0 | 2 |
| AMED | AMEDISYS INC | 200,300 | $8.07K | 0 | 1 | 0 | 0 | 1 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 200,000 | $5.31K | 1 | 0 | 0 | 0 | 1 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 190,600 | $22.67K | 1 | 1 | 0 | 0 | 2 |
| EBS | EMERGENT BIOSOLUTIONS INC | 177,400 | $16.02K | 0 | 1 | 0 | 0 | 1 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 166,300 | $8.71K | 0 | 1 | 0 | 0 | 2 |
| REGN | REGENERON PHARMACEUTICALS | 156,927 | $129.97K | 1 | 1 | 0 | 1 | 2 |
| NEO | NEOGENOMICS INC | 156,100 | $1.92K | 0 | 1 | 0 | 0 | 1 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 142,903 | $1.48K | 1 | 0 | 0 | 0 | 1 |
| ENZ | ENZO BIOCHEM INC | 139,900 | $2.11K | 0 | 1 | 0 | 0 | 1 |
| VRTX | VERTEX PHARMACEUTICALS INC | 138,526 | $46.59K | 1 | 1 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q4 2015
What are the most bought Healthcare stocks in Q4 2015?
The most bought healthcare stocks in Q4 2015 are those with the largest increase in reported share counts across institutional investors compared to Q3 2015, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2015?
Among filers in this sector, net additions were largest in companies such as TEVA PHARMACEUTICAL-SP ADR (TEVA), ASTRAZENECA PLC-SPONS ADR (AZN), AGILENT TECHNOLOGIES INC (A), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2015).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.